Number of Doses and Time to Onset Of Pain Relief (Analgesic Effect) Using the IONSYS System [Fentanyl Iontophoretic Transdermal System (40 microg)].

Trial Profile

Number of Doses and Time to Onset Of Pain Relief (Analgesic Effect) Using the IONSYS System [Fentanyl Iontophoretic Transdermal System (40 microg)].

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2016

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 12 Aug 2016 Status changed from completed to discontinued.
    • 25 Sep 2015 According to The Medicines Company media release, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending marketing authorization for IONSYS for treatment of poost-operative pain in adult patients.
    • 30 Apr 2015 According to The Medicines Company media release, company has received USFDA approval for IONSYS.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top